Financial Planning & Information Services Inc. boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 678 shares of the healthcare conglomerate’s stock after purchasing an additional 36 shares during the quarter. Financial Planning & Information Services Inc.’s holdings in UnitedHealth Group were worth $252,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently modified their holdings of UNH. Toth Financial Advisory Corp raised its holdings in shares of UnitedHealth Group by 3.1% in the 1st quarter. Toth Financial Advisory Corp now owns 17,258 shares of the healthcare conglomerate’s stock valued at $6,421,000 after acquiring an additional 527 shares in the last quarter. Cabot Wealth Management Inc. purchased a new stake in shares of UnitedHealth Group in the 1st quarter valued at about $474,000. Sky Investment Group LLC raised its holdings in shares of UnitedHealth Group by 0.5% in the 1st quarter. Sky Investment Group LLC now owns 10,341 shares of the healthcare conglomerate’s stock valued at $3,848,000 after acquiring an additional 55 shares in the last quarter. Marshall Financial Group LLC purchased a new stake in shares of UnitedHealth Group in the 1st quarter valued at about $214,000. Finally, Fortem Financial Group LLC raised its holdings in shares of UnitedHealth Group by 14.8% during the 1st quarter. Fortem Financial Group LLC now owns 776 shares of the healthcare conglomerate’s stock valued at $289,000 after buying an additional 100 shares in the last quarter. Institutional investors and hedge funds own 86.03% of the company’s stock.
In related news, CAO Thomas E. Roos sold 619 shares of the company’s stock in a transaction on Tuesday, February 9th. The stock was sold at an average price of $323.90, for a total transaction of $200,494.10. Following the completion of the sale, the chief accounting officer now owns 31,908 shares in the company, valued at $10,335,001.20. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction on Monday, April 19th. The shares were sold at an average price of $391.25, for a total value of $978,125.00. Following the sale, the director now owns 154,181 shares of the company’s stock, valued at approximately $60,323,316.25. The disclosure for this sale can be found here. Insiders sold 15,119 shares of company stock valued at $5,440,869 in the last 90 days. Company insiders own 0.80% of the company’s stock.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $4.38 by $0.93. UnitedHealth Group had a return on equity of 27.53% and a net margin of 6.62%. The firm had revenue of $70.20 billion during the quarter, compared to analysts’ expectations of $69.13 billion. During the same quarter in the previous year, the business earned $3.72 earnings per share. The company’s revenue was up 9.0% on a year-over-year basis. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 16.75 EPS for the current year.
The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 23rd. Stockholders of record on Monday, March 15th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.27%. The ex-dividend date of this dividend was Friday, March 12th. UnitedHealth Group’s dividend payout ratio is currently 33.09%.
A number of equities analysts recently weighed in on the company. Oppenheimer raised their price objective on UnitedHealth Group from $375.00 to $440.00 and gave the company an “outperform” rating in a report on Thursday. Deutsche Bank Aktiengesellschaft raised their price objective on UnitedHealth Group from $409.00 to $418.00 and gave the company a “buy” rating in a report on Thursday. Barclays lifted their price target on UnitedHealth Group from $405.00 to $435.00 and gave the stock an “overweight” rating in a research note on Thursday. Bank of America reaffirmed a “buy” rating and issued a $415.00 price target on shares of UnitedHealth Group in a research note on Thursday, January 21st. Finally, Argus raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $450.00 price target on the stock in a research note on Wednesday. Three research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has issued a strong buy rating to the company. UnitedHealth Group presently has an average rating of “Buy” and a consensus price target of $409.61.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, Children's Health Insurance Program, and health care programs; medical and dental benefits; and health care delivery.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.